GlaxoSmithKline plc 12.3% Potential Upside Indicated by UBS

Broker Ratings

GlaxoSmithKline plc with EPIC/TICKER (LON:GSK) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at UBS. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. UBS have set a target price of 1920 GBX on its stock. This is indicating the analyst believes there is a potential upside of 12.3% from the opening price of 1709 GBX. Over the last 30 and 90 trading days the company share price has increased 139 points and increased 26.8 points respectively. The 52 week high share price is 1857 GBX while the 52 week low is 1328.19 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,596.91 GBX and the 200 Day Moving Average price is recorded at 1,701.00. There are currently 5,017,083,206 shares in issue with the average daily volume traded being 10,402,829. Market capitalisation for LON:GSK is £84,467,611,631 GBP.

You might also enjoy reading  GSK plc - Consensus Indicates Potential 48.9% Upside

Good news travels fast (but only if you make that happen). Share on:

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on reddit

AIM All Share Index